AP3D1
Basic information
Region (hg38): 19:2100988-2164468
Links
Phenotypes
GenCC
Source:
- Hermansky-Pudlak syndrome 10 (Moderate), mode of inheritance: AR
- Hermansky-Pudlak syndrome 10 (Limited), mode of inheritance: Unknown
- Hermansky-Pudlak syndrome 10 (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hermansky-Pudlak syndrome 10 | AR | Allergy/Immunology/Infectious | The condition can involve neutropenia and susceptibility to infections, and prompt and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Neurologic; Ophthalmologic | 26744459 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AP3D1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 273 | 12 | 291 | |||
missense | 400 | 11 | 413 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 13 | 14 | ||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 41 | 50 | 7 | 98 | ||
non coding | 215 | 92 | 314 | |||
Total | 0 | 1 | 433 | 500 | 106 |
Variants in AP3D1
This is a list of pathogenic ClinVar variants found in the AP3D1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-2102028-G-A | Likely benign (May 16, 2021) | |||
19-2102181-T-C | Inborn genetic diseases | Uncertain significance (Dec 30, 2023) | ||
19-2102184-C-T | Hermansky-Pudlak syndrome 10 • AP3D1-related disorder | Uncertain significance (Jan 03, 2024) | ||
19-2102187-G-A | Likely benign (Dec 20, 2022) | |||
19-2102188-C-T | Likely benign (Dec 11, 2023) | |||
19-2102189-G-A | Uncertain significance (Aug 18, 2023) | |||
19-2102192-G-A | Uncertain significance (Oct 24, 2023) | |||
19-2102194-C-T | Likely benign (Nov 03, 2023) | |||
19-2102199-T-C | Uncertain significance (Dec 28, 2023) | |||
19-2102200-C-T | Likely benign (Mar 12, 2022) | |||
19-2102205-C-T | Uncertain significance (Nov 28, 2023) | |||
19-2102206-T-C | AP3D1-related disorder | Likely benign (Jan 08, 2024) | ||
19-2102216-C-G | Uncertain significance (Oct 27, 2020) | |||
19-2102224-C-T | AP3D1-related disorder | Likely benign (Nov 15, 2022) | ||
19-2102225-G-A | not specified • Inborn genetic diseases | Uncertain significance (Jan 18, 2024) | ||
19-2102245-G-A | Likely benign (May 14, 2022) | |||
19-2102247-C-T | Uncertain significance (Nov 27, 2023) | |||
19-2102248-G-A | Likely benign (Sep 27, 2022) | |||
19-2102254-GAC-G | Hermansky-Pudlak syndrome 10 | Pathogenic (Jul 27, 2016) | ||
19-2102258-G-C | Uncertain significance (Jan 13, 2023) | |||
19-2102277-G-C | Likely benign (Feb 07, 2023) | |||
19-2102280-A-G | Likely benign (Feb 22, 2023) | |||
19-2102287-T-C | Likely benign (Jan 06, 2024) | |||
19-2102511-C-G | Benign (Dec 24, 2018) | |||
19-2102544-G-C | Benign (Dec 24, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AP3D1 | protein_coding | protein_coding | ENST00000355272 | 32 | 63477 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.986 | 0.0135 | 124822 | 0 | 23 | 124845 | 0.0000921 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.94 | 603 | 753 | 0.801 | 0.0000483 | 7960 |
Missense in Polyphen | 98 | 202.08 | 0.48496 | 2081 | ||
Synonymous | -2.24 | 384 | 332 | 1.16 | 0.0000250 | 2283 |
Loss of Function | 5.97 | 11 | 61.5 | 0.179 | 0.00000279 | 759 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000485 | 0.000479 |
Ashkenazi Jewish | 0.000101 | 0.0000993 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.0000746 | 0.0000706 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000667 | 0.0000654 |
Other | 0.000171 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. Involved in process of CD8+ T-cell and NK cell degranulation (PubMed:26744459). In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals (By similarity). {ECO:0000250|UniProtKB:O54774, ECO:0000269|PubMed:26744459}.;
- Pathway
- Lysosome - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.188
Intolerance Scores
- loftool
- 0.225
- rvis_EVS
- -2.28
- rvis_percentile_EVS
- 1.24
Haploinsufficiency Scores
- pHI
- 0.315
- hipred
- Y
- hipred_score
- 0.601
- ghis
- 0.633
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.844
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ap3d1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- protein targeting to vacuole;eye pigment biosynthetic process;intracellular protein transport;Golgi to vacuole transport;anterograde axonal transport;synaptic vesicle budding from endosome;melanosome organization;endosome to melanosome transport;antigen processing and presentation, exogenous lipid antigen via MHC class Ib;anterograde synaptic vesicle transport;synaptic vesicle membrane organization;positive regulation of NK T cell differentiation;regulation of sequestering of zinc ion;protein localization to membrane;neurotransmitter receptor transport, postsynaptic endosome to lysosome
- Cellular component
- Golgi membrane;lysosomal membrane;Golgi apparatus;plasma membrane;endosome membrane;membrane;AP-3 adaptor complex;terminal bouton;postsynapse;presynaptic endosome;glutamatergic synapse;axon cytoplasm
- Molecular function
- transporter activity